ROCKVILLE, Md., Sept. 18 /PRNewswire/ -- BioReliance Corporation, a
leading contract services organization for the biopharmaceutical and
pharmaceutical industries, announced today the launch of iNet, a
proprietary information technology system that enables customers to submit
test article details via controlled and secure Internet access from any
location worldwide. In real-time, BioReliance clients can now view the
status of current and past studies, keep informed of expected completion
dates, download reports, and allow colleagues to view testing status-all in
one online environment.

BioReliance developed iNet to simplify test article submissions and to
promote instantaneous communications between clients and internal project
managers. "As a result of these efforts," stated Tim Derrington, President
and CEO of BioReliance, "our customers are now armed with a web-enabled
application that offers a precise picture of their project's current and
future status. We look forward to greatly expanding our iNet user base in
the upcoming months and continuing to develop and integrate new
technologies that will enhance our customers' service experiences with
BioReliance."

Pavel Khrimian, Senior Project Manager, commented, "The response from
our early-access iNet users has been very positive. Customers are using the
projected lab initiation and report completion dates to facilitate their
project planning efforts. In addition, the electronic template used for
sample submission has simplified their paperwork, while making the entire
process more timely and manageable."

Judith Apshago, Senior Director of Global IT, also added, "A lot of
effort was placed into making iNet user-friendly, secure and compliant. As
a result, preliminary users have navigated through the submission process
with little difficulty. In addition, we have implemented multiple layers of
security both on the front end and the back end to create an extremely
secure online environment that validates users and ensures data integrity."

iNet is compliant with 21 CFR Part 11 for user authentication, and data
exchange over the web is protected by use of Secured Sockets Layer
certificates procured from VeriSign(R). It is also compatible with both
Windows and Mac operating systems.

The iNet application is available to US biologics testing customers
upon request. This service will be available at a future date for studies
conducted in the UK, as well as for viral clearance and toxicology clients.

About BioReliance

BioReliance Corporation is a leading contract services organization,
offering more than 1,000 tests or services related to biologics safety
testing, in vitro and in vivo toxicology, viral manufacturing and lab
animal health diagnostics for the biopharmaceutical and pharmaceutical
industries. The Company provides cost-effective services to over 600
clients annually, including most of the largest pharmaceutical and
biopharmaceutical companies in the world. BioReliance is headquartered in
Rockville, Maryland and has additional facilities in Glasgow, Scotland and
Stirling, Scotland. For more information, visit http://www.bioreliance.com.

(Date:12/6/2016)... -- Valencell , the leading innovator in performance ... third consecutive year of triple digit growth for its ... a 360 percent increase in companies who have acquired ... by sales of its wrist and ear Benchmark™ sensor ... for hearables for fitness and healthcare applications. ...

(Date:11/30/2016)... , Nov. 30, 2016 higi SH llc ... partnership initiative targeting national brands, industry thought-leaders and ... their respective audiences for taking steps to live ... inception in 2012, higi has built the largest ... over 38 million people who have conducted over ...